{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:33:18Z","timestamp":1789914798622,"version":"4.0.1"},"reference-count":23,"publisher":"American Psychiatric Association Publishing","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AJP"],"published-print":{"date-parts":[[2003,8,1]]},"DOI":"10.1176\/appi.ajp.160.8.1432","type":"journal-article","created":{"date-parts":[[2003,8,4]],"date-time":"2003-08-04T17:35:14Z","timestamp":1060018514000},"page":"1432-1438","source":"Crossref","is-referenced-by-count":103,"title":["Are Benzodiazepines Still the Medication of Choice for Patients With Panic Disorder With or Without Agoraphobia?"],"prefix":"10.1176","volume":"160","author":[{"given":"Steven E.","family":"Bruce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell G.","family":"Vasile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Goisman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Salzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Spencer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason T.","family":"Machan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin B.","family":"Keller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"230","reference":[{"key":"R1608CACDBGCI","doi-asserted-by":"crossref","unstructured":"Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H-U, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8\u201319","DOI":"10.1001\/archpsyc.1994.03950010008002"},{"key":"R1608CACCDHHF","unstructured":"Weissman MM, Bland RC, Canino GJ, Faravelli C, Greenwald S, Hwu HG, Joyce PR, Karam EG, Lee CK, Lellouch J, Lepine JP, Newman SC, Oakley-Browne MA, Rubio-Stipec M, Wells JE, Wickramaratne PJ, Wittchen HU, Yeh EK: The cross-national epidemiology of panic disorder. Arch Gen Psychiatry 1997; 54:305\u2013309"},{"key":"R1608CACEEGCE","doi-asserted-by":"crossref","unstructured":"Kessler R, Stang PE, Wittchen H, Ustun TB, Roy-Byrne PP, Walters EE: Lifetime panic-depression comorbidity in the National Comorbidity Survey. Arch Gen Psychiatry 1998; 55:801\u2013808","DOI":"10.1001\/archpsyc.55.9.801"},{"key":"R1608CACCFCIJ","unstructured":"Wade AG: Antidepressants in panic disorder. Int Clin Psychopharmacol 1999; 14(suppl 2):S13-S17"},{"key":"R1608CACGFFHG","doi-asserted-by":"crossref","unstructured":"Nutt D: Treatment of depression and concomitant anxiety. Eur Neuropsychopharmacol 2000; 10(suppl 4):S433-S437","DOI":"10.1016\/S0924-977X(00)00110-3"},{"key":"R1608CACGCACF","unstructured":"Kuzel R: Treating comorbid depression and anxiety. J Fam Pract 1996; 43(suppl 6):S45-S53"},{"key":"R1608CACBHHJE","unstructured":"Ballenger JC, Davidson JRT, Lecrubier Y, Nutt DJ, Baldwin DS, den Boer JA, Kasper S, Shear MK: Consensus statement on panic disorder from the International Consensus Group on Depression and Anxiety. J Clin Psychiatry 1998; 59:47\u201354"},{"key":"R1608CACHJEIE","unstructured":"American Psychiatric Association: Practice Guideline for the Treatment of Patients With Panic Disorder. Am J Psychiatry 1998; 155(May suppl)"},{"key":"R1608CACHJBBE","doi-asserted-by":"crossref","unstructured":"Haddad P: The SSRI discontinuation syndrome. J Psychopharmacol 1998; 12:305\u2013313","DOI":"10.1177\/026988119801200311"},{"key":"R1608CACHBADB","unstructured":"Black K, Shea C, Dursun S, Kutcher S: Selective serotonin reuptake inhibitor discontinuation syndrome: proposed diagnostic criteria. J Psychiatry Neurosci 2000; 25:255\u2013261"},{"key":"R1608CACJIGCD","doi-asserted-by":"crossref","unstructured":"Keller MB, Yonkers KA, Warshaw MG, Pratt LA, Gollan JK, Massion AO, White K, Swartz AR, Reich J, Lavori PW: Remission and relapse in subjects with panic disorder and panic with agoraphobia: a prospective short-interval naturalistic follow-up. J Nerv Ment Dis 1994; 182:290\u2013296","DOI":"10.1097\/00005053-199405000-00007"},{"key":"R1608CACFDAHA","doi-asserted-by":"crossref","unstructured":"Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott P, Andreasen NC: The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Arch Gen Psychiatry 1987; 44:540\u2013548","DOI":"10.1001\/archpsyc.1987.01800180050009"},{"key":"R1608CACBJCFJ","doi-asserted-by":"crossref","unstructured":"Warshaw MG, Keller MB, Stout RL: Reliability and validity of the Longitudinal Interval Follow-Up Evaluation for assessing outcome of anxiety disorders. J Psychiatr Res 1994; 28:531\u2013545","DOI":"10.1016\/0022-3956(94)90043-4"},{"key":"R1608CACJAIFD","doi-asserted-by":"crossref","unstructured":"Uhlenhuth EH, Balter MB, Ban TA, Yang K: International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications, VI: trends in recommendations for the pharmacotherapy of anxiety disorders, 1992\u20131997. Depress Anxiety 1999; 9:107\u2013116","DOI":"10.1002\/(SICI)1520-6394(1999)9:3<107::AID-DA2>3.0.CO;2-T"},{"key":"R1608CACCCFDB","doi-asserted-by":"crossref","unstructured":"Salzman C, Goldenberg I, Bruce SE, Keller MB: Pharmacologic treatment of anxiety disorders in 1989 versus 1996: results from the Harvard\/Brown Anxiety Disorders Research Program. J Clin Psychiatry 2001; 62:149\u2013152","DOI":"10.4088\/JCP.v62n0302"},{"key":"R1608CACBGCJI","doi-asserted-by":"crossref","unstructured":"Lomas J, Anderson GM, Domnick-Pierre K, Vayda E, Enkin MW, Hannah WJ: Do practice guidelines guide practice? the effect of a consensus statement on the practice of physicians. N Engl J Med 1989; 321:1306\u20131311","DOI":"10.1056\/NEJM198911093211906"},{"key":"R1608CACDCHCJ","unstructured":"Ferrier B, Woodward CA, Cohen M, Williams AP: Clinical practice guidelines: new-to-practice family physicians\u2019 attitudes. Can Fam Physician 1996; 42:463\u2013468"},{"key":"R1608CACDIBEI","doi-asserted-by":"crossref","unstructured":"Grilli R, Lomas J: Evaluating the message: the relationship between compliance rate and the subject of the practice guideline. Med Care 1994; 32:202\u2013213","DOI":"10.1097\/00005650-199403000-00002"},{"key":"R1608CACGGECI","doi-asserted-by":"crossref","unstructured":"Cowley DS, Ha EH, Roy Byrne PP: Determinants of pharmacologic treatment failure in panic disorder. J Clin Psychiatry 1997; 58:555\u2013561","DOI":"10.4088\/JCP.v58n1208"},{"key":"R1608CACHJIGC","doi-asserted-by":"crossref","unstructured":"Clayton AH, Pradko JF, Croft HA, Montano CB, Leadbetter RA, Bolden-Watson C, Bass KI, Donahue RMJ, Jamerson BD, Metz A: Prevalence of sexual dysfunction among newer antidepressants. J Clin Psychiatry 2002; 63:357\u2013366","DOI":"10.4088\/JCP.v63n0414"},{"key":"R1608CACHECHE","doi-asserted-by":"crossref","unstructured":"Otto MW, Tuby KS, Gould RA, McLean RYS, Pollack MH: An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder. Am J Psychiatry 2001; 158:1989\u20131992","DOI":"10.1176\/appi.ajp.158.12.1989"},{"key":"R1608CACIBHBF","doi-asserted-by":"crossref","unstructured":"Goisman RM, Warshaw MG, Keller MB: Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991\u20131996. Am J Psychiatry 1999; 156:1819\u20131821","DOI":"10.1176\/ajp.156.11.1819"},{"key":"R1608CACDEJIJ","unstructured":"Goisman RM, Rogers MP, Steketee GS, Warshaw MG, Cuneo P, Keller MB: Utilization of behavioral methods in a multicenter anxiety disorders study. J Clin Psychiatry 1993; 54:213\u2013218"}],"container-title":["American Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.8.1432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,30]],"date-time":"2024-07-30T19:01:09Z","timestamp":1722366069000},"score":1,"resource":{"primary":{"URL":"https:\/\/psychiatryonline.org\/doi\/10.1176\/appi.ajp.160.8.1432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,8,1]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,8,1]]}},"alternative-id":["10.1176\/appi.ajp.160.8.1432"],"URL":"https:\/\/doi.org\/10.1176\/appi.ajp.160.8.1432","relation":{},"ISSN":["0002-953X","1535-7228"],"issn-type":[{"value":"0002-953X","type":"print"},{"value":"1535-7228","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,8,1]]}}}